APA

Monif T., Rao Thudi N., Koundinya Tippabhotla S., Khuroo A., Marwah A., Kumar Shrivastav V., Tandon M., Raghuvanshi R. & Biswal S. (20080701). A single-dose, randomized, open-label, two-period crossover bioequivalence study of a fixed-dose pediatric combination of lamivudine 40-mg, nevirapine 70-mg, and stavudine 10-mg tablet for oral suspension with individual liquid formulations in healthy adult male volunteers. : Clinical therapeutics.

Chicago

Monif Tausif, Rao Thudi Nageshwar, Koundinya Tippabhotla Sudhakar, Khuroo Arshad, Marwah Amit, Kumar Shrivastav Vikesh, Tandon Monika, Raghuvanshi Rajeev and Biswal Shibadas. 20080701. A single-dose, randomized, open-label, two-period crossover bioequivalence study of a fixed-dose pediatric combination of lamivudine 40-mg, nevirapine 70-mg, and stavudine 10-mg tablet for oral suspension with individual liquid formulations in healthy adult male volunteers. : Clinical therapeutics.

Harvard

Monif T., Rao Thudi N., Koundinya Tippabhotla S., Khuroo A., Marwah A., Kumar Shrivastav V., Tandon M., Raghuvanshi R. and Biswal S. (20080701). A single-dose, randomized, open-label, two-period crossover bioequivalence study of a fixed-dose pediatric combination of lamivudine 40-mg, nevirapine 70-mg, and stavudine 10-mg tablet for oral suspension with individual liquid formulations in healthy adult male volunteers. : Clinical therapeutics.

MLA

Monif Tausif, Rao Thudi Nageshwar, Koundinya Tippabhotla Sudhakar, Khuroo Arshad, Marwah Amit, Kumar Shrivastav Vikesh, Tandon Monika, Raghuvanshi Rajeev and Biswal Shibadas. A single-dose, randomized, open-label, two-period crossover bioequivalence study of a fixed-dose pediatric combination of lamivudine 40-mg, nevirapine 70-mg, and stavudine 10-mg tablet for oral suspension with individual liquid formulations in healthy adult male volunteers. : Clinical therapeutics. 20080701.